Pharmaceutical composition intended to inhibit the infectivity of HIV, to treat acquired immunodeficiency syndrome (AIDS) and its complications
FR3065878A1
Pharmaceutical composition, characterized in that it includes, as active ingredient, a combination of beta-elemene, lupeol, acemannane and an agent
FR3061658A1
Pharmaceutical composition comprising as active ingredient a combination of d-limoneme, lupeol and cinnamaldehyde and / or polymeric methylhydroxychalcone and / or beta-sitosterol and / or
FR3058058A1
Pharmaceutical composition comprising as active ingredient a combination of beta-elemene, lupeol and 2-hydroxycinnamaldehyde and / or 2-benzoyloxycinnalmaldehyde and / or beta-sitosterol
